Phio Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $70 | $0 |
Gross Profit | 35 | -644 | ||
EBITDA | -2,309 | -1,769 | -1,674 | -1,590 |
EBIT | -1,639 | -1,625 | ||
Net Income | -2,166 | -1,769 | -1,626 | -1,524 |
Net Change In Cash | 0 | 0 | 70 | 0 |
Free Cash Flow | -2,543 | -1,277 | -1,372 | -1,360 |
Cash | 10,775 | 13,278 | 5,382 | 5,390 |
Basic Shares | 4,794 | 7,874 | 990 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -35 | -6,332 | -193 | -192 |
EBITDA | -7,115 | -10,642 | -11,269 | -13,436 |
EBIT | -7,150 | -10,826 | -11,462 | -13,511 |
Net Income | -7,150 | -10,826 | -11,305 | -13,212 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,113 | -10,754 | -12,250 | -11,909 |
Cash | 5,382 | 8,490 | 11,781 | 24,057 |
Basic Shares | 7,874 | 231 | 126 | 118 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.45 |
2025-03-31 | -$0.93 |
2024-12-31 | -$0.85 |
2024-09-30 | -$1.54 |
